The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intraocular Injections Market Research Report 2025
Synopsis
Intraocular injection refers to a sterile liquid preparation made of raw materials and excipients, which is used for injection into tissues around the eye or into the eye (including anterior chamber injection, anterior chamber irrigation, intravitreal injection, intravitreal perfusion, etc.).
The global Intraocular Injections market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Intraocular Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intraocular Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intraocular Injections include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Novartis, Genentech, Apellis Pharmaceuticals, Inc., Iveric Bio, Qilu Pharmaceutical, Chengdu Kanghong Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intraocular Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intraocular Injections.
The Intraocular Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Intraocular Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intraocular Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Novartis
Genentech
Apellis Pharmaceuticals, Inc.
Iveric Bio
Qilu Pharmaceutical
Chengdu Kanghong Pharmaceutical
Segment by Type
Monoclonal Antibody Type
Receptor-Antibody Fusion Protein Type
Segment by Application
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intraocular Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intraocular Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intraocular injection refers to a sterile liquid preparation made of raw materials and excipients, which is used for injection into tissues around the eye or into the eye (including anterior chamber injection, anterior chamber irrigation, intravitreal injection, intravitreal perfusion, etc.).
The global Intraocular Injections market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Intraocular Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intraocular Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intraocular Injections include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Novartis, Genentech, Apellis Pharmaceuticals, Inc., Iveric Bio, Qilu Pharmaceutical, Chengdu Kanghong Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intraocular Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intraocular Injections.
The Intraocular Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Intraocular Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intraocular Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Novartis
Genentech
Apellis Pharmaceuticals, Inc.
Iveric Bio
Qilu Pharmaceutical
Chengdu Kanghong Pharmaceutical
Segment by Type
Monoclonal Antibody Type
Receptor-Antibody Fusion Protein Type
Segment by Application
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intraocular Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intraocular Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intraocular Injections Market Overview
1.1 Product Definition
1.2 Intraocular Injections by Type
1.2.1 Global Intraocular Injections Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibody Type
1.2.3 Receptor-Antibody Fusion Protein Type
1.3 Intraocular Injections by Application
1.3.1 Global Intraocular Injections Market Value by Application (2024-2030)
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Global Intraocular Injections Market Size Estimates and Forecasts
1.4.1 Global Intraocular Injections Revenue 2019-2030
1.4.2 Global Intraocular Injections Sales 2019-2030
1.4.3 Global Intraocular Injections Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intraocular Injections Market Competition by Manufacturers
2.1 Global Intraocular Injections Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intraocular Injections Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intraocular Injections Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Intraocular Injections, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intraocular Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intraocular Injections, Product Type & Application
2.7 Global Key Manufacturers of Intraocular Injections, Date of Enter into This Industry
2.8 Global Intraocular Injections Market Competitive Situation and Trends
2.8.1 Global Intraocular Injections Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intraocular Injections Players Market Share by Revenue
2.8.3 Global Intraocular Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intraocular Injections Market Scenario by Region
3.1 Global Intraocular Injections Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intraocular Injections Sales by Region: 2019-2030
3.2.1 Global Intraocular Injections Sales by Region: 2019-2024
3.2.2 Global Intraocular Injections Sales by Region: 2025-2030
3.3 Global Intraocular Injections Revenue by Region: 2019-2030
3.3.1 Global Intraocular Injections Revenue by Region: 2019-2024
3.3.2 Global Intraocular Injections Revenue by Region: 2025-2030
3.4 North America Intraocular Injections Market Facts & Figures by Country
3.4.1 North America Intraocular Injections Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intraocular Injections Sales by Country (2019-2030)
3.4.3 North America Intraocular Injections Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intraocular Injections Market Facts & Figures by Country
3.5.1 Europe Intraocular Injections Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intraocular Injections Sales by Country (2019-2030)
3.5.3 Europe Intraocular Injections Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intraocular Injections Market Facts & Figures by Region
3.6.1 Asia Pacific Intraocular Injections Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intraocular Injections Sales by Region (2019-2030)
3.6.3 Asia Pacific Intraocular Injections Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intraocular Injections Market Facts & Figures by Country
3.7.1 Latin America Intraocular Injections Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intraocular Injections Sales by Country (2019-2030)
3.7.3 Latin America Intraocular Injections Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intraocular Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Intraocular Injections Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intraocular Injections Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intraocular Injections Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intraocular Injections Sales by Type (2019-2030)
4.1.1 Global Intraocular Injections Sales by Type (2019-2024)
4.1.2 Global Intraocular Injections Sales by Type (2025-2030)
4.1.3 Global Intraocular Injections Sales Market Share by Type (2019-2030)
4.2 Global Intraocular Injections Revenue by Type (2019-2030)
4.2.1 Global Intraocular Injections Revenue by Type (2019-2024)
4.2.2 Global Intraocular Injections Revenue by Type (2025-2030)
4.2.3 Global Intraocular Injections Revenue Market Share by Type (2019-2030)
4.3 Global Intraocular Injections Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intraocular Injections Sales by Application (2019-2030)
5.1.1 Global Intraocular Injections Sales by Application (2019-2024)
5.1.2 Global Intraocular Injections Sales by Application (2025-2030)
5.1.3 Global Intraocular Injections Sales Market Share by Application (2019-2030)
5.2 Global Intraocular Injections Revenue by Application (2019-2030)
5.2.1 Global Intraocular Injections Revenue by Application (2019-2024)
5.2.2 Global Intraocular Injections Revenue by Application (2025-2030)
5.2.3 Global Intraocular Injections Revenue Market Share by Application (2019-2030)
5.3 Global Intraocular Injections Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Regeneron Pharmaceuticals (Eylea)
6.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
6.1.2 Regeneron Pharmaceuticals (Eylea) Description and Business Overview
6.1.3 Regeneron Pharmaceuticals (Eylea) Intraocular Injections Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Regeneron Pharmaceuticals (Eylea) Intraocular Injections Product Portfolio
6.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Company Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Intraocular Injections Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan Intraocular Injections Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 EyePoint Pharmaceuticals
6.3.1 EyePoint Pharmaceuticals Company Information
6.3.2 EyePoint Pharmaceuticals Description and Business Overview
6.3.3 EyePoint Pharmaceuticals Intraocular Injections Sales, Revenue and Gross Margin (2019-2024)
6.3.4 EyePoint Pharmaceuticals Intraocular Injections Product Portfolio
6.3.5 EyePoint Pharmaceuticals Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Intraocular Injections Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Intraocular Injections Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Genentech
6.5.1 Genentech Company Information
6.5.2 Genentech Description and Business Overview
6.5.3 Genentech Intraocular Injections Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Genentech Intraocular Injections Product Portfolio
6.5.5 Genentech Recent Developments/Updates
6.6 Apellis Pharmaceuticals, Inc.
6.6.1 Apellis Pharmaceuticals, Inc. Company Information
6.6.2 Apellis Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Apellis Pharmaceuticals, Inc. Intraocular Injections Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Apellis Pharmaceuticals, Inc. Intraocular Injections Product Portfolio
6.6.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
6.7 Iveric Bio
6.7.1 Iveric Bio Company Information
6.7.2 Iveric Bio Description and Business Overview
6.7.3 Iveric Bio Intraocular Injections Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Iveric Bio Intraocular Injections Product Portfolio
6.7.5 Iveric Bio Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Company Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Intraocular Injections Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qilu Pharmaceutical Intraocular Injections Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Chengdu Kanghong Pharmaceutical
6.9.1 Chengdu Kanghong Pharmaceutical Company Information
6.9.2 Chengdu Kanghong Pharmaceutical Description and Business Overview
6.9.3 Chengdu Kanghong Pharmaceutical Intraocular Injections Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chengdu Kanghong Pharmaceutical Intraocular Injections Product Portfolio
6.9.5 Chengdu Kanghong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intraocular Injections Industry Chain Analysis
7.2 Intraocular Injections Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intraocular Injections Production Mode & Process
7.4 Intraocular Injections Sales and Marketing
7.4.1 Intraocular Injections Sales Channels
7.4.2 Intraocular Injections Distributors
7.5 Intraocular Injections Customers
8 Intraocular Injections Market Dynamics
8.1 Intraocular Injections Industry Trends
8.2 Intraocular Injections Market Drivers
8.3 Intraocular Injections Market Challenges
8.4 Intraocular Injections Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Intraocular Injections Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Intraocular Injections Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Intraocular Injections Market Competitive Situation by Manufacturers in 2023
Table 4. Global Intraocular Injections Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Intraocular Injections Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Intraocular Injections Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Intraocular Injections Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Intraocular Injections Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Intraocular Injections, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Intraocular Injections, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intraocular Injections, Product Type & Application
Table 12. Global Key Manufacturers of Intraocular Injections, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intraocular Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intraocular Injections as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intraocular Injections Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Intraocular Injections Sales by Region (2019-2024) & (K Units)
Table 18. Global Intraocular Injections Sales Market Share by Region (2019-2024)
Table 19. Global Intraocular Injections Sales by Region (2025-2030) & (K Units)
Table 20. Global Intraocular Injections Sales Market Share by Region (2025-2030)
Table 21. Global Intraocular Injections Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Intraocular Injections Revenue Market Share by Region (2019-2024)
Table 23. Global Intraocular Injections Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Intraocular Injections Revenue Market Share by Region (2025-2030)
Table 25. North America Intraocular Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Intraocular Injections Sales by Country (2019-2024) & (K Units)
Table 27. North America Intraocular Injections Sales by Country (2025-2030) & (K Units)
Table 28. North America Intraocular Injections Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Intraocular Injections Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Intraocular Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Intraocular Injections Sales by Country (2019-2024) & (K Units)
Table 32. Europe Intraocular Injections Sales by Country (2025-2030) & (K Units)
Table 33. Europe Intraocular Injections Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Intraocular Injections Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Intraocular Injections Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Intraocular Injections Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Intraocular Injections Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Intraocular Injections Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Intraocular Injections Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Intraocular Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Intraocular Injections Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Intraocular Injections Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Intraocular Injections Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Intraocular Injections Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Intraocular Injections Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Intraocular Injections Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Intraocular Injections Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Intraocular Injections Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Intraocular Injections Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Intraocular Injections Sales (K Units) by Type (2019-2024)
Table 51. Global Intraocular Injections Sales (K Units) by Type (2025-2030)
Table 52. Global Intraocular Injections Sales Market Share by Type (2019-2024)
Table 53. Global Intraocular Injections Sales Market Share by Type (2025-2030)
Table 54. Global Intraocular Injections Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Intraocular Injections Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Intraocular Injections Revenue Market Share by Type (2019-2024)
Table 57. Global Intraocular Injections Revenue Market Share by Type (2025-2030)
Table 58. Global Intraocular Injections Price (US$/Unit) by Type (2019-2024)
Table 59. Global Intraocular Injections Price (US$/Unit) by Type (2025-2030)
Table 60. Global Intraocular Injections Sales (K Units) by Application (2019-2024)
Table 61. Global Intraocular Injections Sales (K Units) by Application (2025-2030)
Table 62. Global Intraocular Injections Sales Market Share by Application (2019-2024)
Table 63. Global Intraocular Injections Sales Market Share by Application (2025-2030)
Table 64. Global Intraocular Injections Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Intraocular Injections Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Intraocular Injections Revenue Market Share by Application (2019-2024)
Table 67. Global Intraocular Injections Revenue Market Share by Application (2025-2030)
Table 68. Global Intraocular Injections Price (US$/Unit) by Application (2019-2024)
Table 69. Global Intraocular Injections Price (US$/Unit) by Application (2025-2030)
Table 70. Regeneron Pharmaceuticals (Eylea) Company Information
Table 71. Regeneron Pharmaceuticals (Eylea) Description and Business Overview
Table 72. Regeneron Pharmaceuticals (Eylea) Intraocular Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Regeneron Pharmaceuticals (Eylea) Intraocular Injections Product
Table 74. Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
Table 75. Allergan Company Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Intraocular Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Allergan Intraocular Injections Product
Table 79. Allergan Recent Developments/Updates
Table 80. EyePoint Pharmaceuticals Company Information
Table 81. EyePoint Pharmaceuticals Description and Business Overview
Table 82. EyePoint Pharmaceuticals Intraocular Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. EyePoint Pharmaceuticals Intraocular Injections Product
Table 84. EyePoint Pharmaceuticals Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Intraocular Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Novartis Intraocular Injections Product
Table 89. Novartis Recent Developments/Updates
Table 90. Genentech Company Information
Table 91. Genentech Description and Business Overview
Table 92. Genentech Intraocular Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Genentech Intraocular Injections Product
Table 94. Genentech Recent Developments/Updates
Table 95. Apellis Pharmaceuticals, Inc. Company Information
Table 96. Apellis Pharmaceuticals, Inc. Description and Business Overview
Table 97. Apellis Pharmaceuticals, Inc. Intraocular Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Apellis Pharmaceuticals, Inc. Intraocular Injections Product
Table 99. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. Iveric Bio Company Information
Table 101. Iveric Bio Description and Business Overview
Table 102. Iveric Bio Intraocular Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Iveric Bio Intraocular Injections Product
Table 104. Iveric Bio Recent Developments/Updates
Table 105. Qilu Pharmaceutical Company Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Intraocular Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Qilu Pharmaceutical Intraocular Injections Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Chengdu Kanghong Pharmaceutical Company Information
Table 111. Chengdu Kanghong Pharmaceutical Description and Business Overview
Table 112. Chengdu Kanghong Pharmaceutical Intraocular Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Chengdu Kanghong Pharmaceutical Intraocular Injections Product
Table 114. Chengdu Kanghong Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Intraocular Injections Distributors List
Table 118. Intraocular Injections Customers List
Table 119. Intraocular Injections Market Trends
Table 120. Intraocular Injections Market Drivers
Table 121. Intraocular Injections Market Challenges
Table 122. Intraocular Injections Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Intraocular Injections
Figure 2. Global Intraocular Injections Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Intraocular Injections Market Share by Type: 2023 & 2030
Figure 4. Monoclonal Antibody Type Product Picture
Figure 5. Receptor-Antibody Fusion Protein Type Product Picture
Figure 6. Global Intraocular Injections Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Intraocular Injections Market Share by Application: 2023 & 2030
Figure 8. Macular Degeneration
Figure 9. Macular Edema
Figure 10. Uveitis
Figure 11. Retinal Vein Occlusion
Figure 12. Others
Figure 13. Global Intraocular Injections Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Intraocular Injections Market Size (2019-2030) & (US$ Million)
Figure 15. Global Intraocular Injections Sales (2019-2030) & (K Units)
Figure 16. Global Intraocular Injections Average Price (US$/Unit) & (2019-2030)
Figure 17. Intraocular Injections Report Years Considered
Figure 18. Intraocular Injections Sales Share by Manufacturers in 2023
Figure 19. Global Intraocular Injections Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Intraocular Injections Players: Market Share by Revenue in Intraocular Injections in 2023
Figure 21. Intraocular Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Intraocular Injections Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Intraocular Injections Sales Market Share by Country (2019-2030)
Figure 24. North America Intraocular Injections Revenue Market Share by Country (2019-2030)
Figure 25. United States Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Intraocular Injections Sales Market Share by Country (2019-2030)
Figure 28. Europe Intraocular Injections Revenue Market Share by Country (2019-2030)
Figure 29. Germany Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Intraocular Injections Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Intraocular Injections Revenue Market Share by Region (2019-2030)
Figure 36. China Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Intraocular Injections Sales Market Share by Country (2019-2030)
Figure 44. Mexico Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Intraocular Injections Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Intraocular Injections Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Intraocular Injections Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Intraocular Injections by Type (2019-2030)
Figure 54. Global Revenue Market Share of Intraocular Injections by Type (2019-2030)
Figure 55. Global Intraocular Injections Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Intraocular Injections by Application (2019-2030)
Figure 57. Global Revenue Market Share of Intraocular Injections by Application (2019-2030)
Figure 58. Global Intraocular Injections Price (US$/Unit) by Application (2019-2030)
Figure 59. Intraocular Injections Value Chain
Figure 60. Intraocular Injections Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
